BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38868532)

  • 21. Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer.
    Zhang Y; Wang Y; Zhang B; Li P; Zhao Y
    Biomed Pharmacother; 2023 Jul; 163():114786. PubMed ID: 37119736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
    Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
    Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches.
    Al-Joufi FA; Setia A; Salem-Bekhit MM; Sahu RK; Alqahtani FY; Widyowati R; Aleanizy FS
    Nanomaterials (Basel); 2022 Jan; 12(1):. PubMed ID: 35010119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress.
    Myint ZW; Goel G
    J Hematol Oncol; 2017 Apr; 10(1):86. PubMed ID: 28434400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical Chimeric Antibody Chimeric Antigen Receptor T Cell Progress in Digestive System Cancers.
    Lü P; Qiu S; Pan Y; Yu F; Chen K
    Cancer Biother Radiopharm; 2021 May; 36(4):307-315. PubMed ID: 33481647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data.
    Rodin AS; Gogoshin G; Hilliard S; Wang L; Egelston C; Rockne RC; Chao J; Lee PP
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Abreu P; Ferreira R; Mineli V; Ribeiro MA; Ferreira FG; DE Mello Vianna RM; Tomasich FDS; Szutan LA
    Anticancer Res; 2020 Dec; 40(12):6573-6784. PubMed ID: 33288552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for immunotherapy of hepatocellular carcinoma.
    Greten TF; Villanueva A; Korangy F; Ruf B; Yarchoan M; Ma L; Ruppin E; Wang XW
    Nat Rev Clin Oncol; 2023 Nov; 20(11):780-798. PubMed ID: 37726418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research.
    Alves Martins BA; de Bulhões GF; Cavalcanti IN; Martins MM; de Oliveira PG; Martins AMA
    Front Oncol; 2019; 9():1284. PubMed ID: 31828035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems immune monitoring in cancer therapy.
    Greenplate AR; Johnson DB; Ferrell PB; Irish JM
    Eur J Cancer; 2016 Jul; 61():77-84. PubMed ID: 27155446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors.
    Sobral PS; Luz VCC; Almeida JMGCF; Videira PA; Pereira F
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma.
    Juratli MA; Pollmann NS; Oppermann E; Mohr A; Roy D; Schnitzbauer A; Michalik S; Vogl T; Stoecklein NH; Houben P; Katou S; Becker F; Hoelzen JP; Andreou A; Pascher A; Bechstein WO; Struecker B
    Sci Rep; 2024 Mar; 14(1):5322. PubMed ID: 38438456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.